Alivus Life Sciences Ltd.

NSE: ALIVUS | BSE: 543322 | ISIN: INE03Q201024 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive
1329.8000 4.60 (0.35%)
NSE Aug 07, 2026 15:31 PM
Volume: 85,268
High vol.+gain this week

logo
Alivus Life Sciences Ltd.
29 Apr 2023
1329.80
0.35%
buy
by BOB Capital Markets Ltd.
Target: 600
BOB Capital Markets Ltd.
Q4 revenue of Rs 6.2bn (+21% YoY) beat our estimate by 14% driven by recovery in CDMO and growth in API
 
Alivus Life Sciences has gained 42.61% in the last 6 Months
More from Alivus Life Sciences Ltd.
Recommended
Five Interesting Stocks Today - August 7, 2026
The Baseline | 07 Aug 2026, 05:41PM
Market closes lower, dragged down by losses in finance and banking stocks
Trendlyne Marketwatch | 07 Aug 2026, 04:05PM
Glenmark Life Sciences: The hived off API business of Glenmark Pharma goes public
| 27 Jul 2021